Abstract
We have carried out a prospective survey of 28 primary liver carcinomas over one year. Hepatocellular carcinoma is the commonest malignancy seen in Rhodesian blacks, which results in a high index of suspicion and accounts for the 96.4% positive diagnosis before death in this study. The age distribution was evenly spread through adult life with no definite peak incidence. Some were young and without evidence of chronic liver disease, but many had the stigmata of established hepatic disease. This contrasts with the common assertion that in areas of high incidence for primary liver cancer those affected are mainly young and lack signs of chronic liver disease. The commonest presenting symptoms were abdominal pain and swelling and weight loss. Hepatomegaly, often tender and nodular, was present in all but one. The incidence of alpha-feto protein, 46.5%, is low compared with other countries where primary liver cancer is common. Hepatitis B antigen was absent in all 28, suggesting that there is no association between the persistence of the antigen and hepatocellular carcinoma in Rhodesia. Liver function tests, although abnormal, were never diagnostic of primary liver cancer. We have confirmed the association of high alcohol consumption and cirrhosis with hepatocellular carcinoma.
Similar content being viewed by others
References
Skinner MEG: Cancer Incidence in Five Continents, Vol. II. A Technical Report. R. Doll, CS Muir JAH Waterhouse, (eds), Geneva, International Union Against Cancer, 1970
Steiner PE: Comparison of liver cancer and cirrhosis in the nine areas in trans-Saharan Africa. Acta Unio Int Contra Cancrum 17:798–825, 1961
Doll R, Payne P, Waterhouse JAH (eds): Cancer Incidence in Five Continents, Vol. 1. A Technical Report Geneva, International Union Against Cancer, 1966
Prates MD: Cancer and cirrhosis of the liver in the Portuguese East African. Acta Unio Int Contra Cancrum 17:718–739, 1961
Higginson J, Steiner PE: Cirrhosis and liver cancer in the non-white population of Johannesburg. Acta Unio Int Contra Cancrum 17:654–666, 1961
O'Conor GT, Tatarinov YuS, Abelev GI, Uriel J: A collaborative study for the evaluation of a serologic test for primary liver cancer. Cancer 25:1091–1098, 1970
Purves LR, Bersohn I, Geddes EW: Serum alpha-feto protein and primary cancer of the liver in man. Cancer 25:1261–1270, 1970
Ashworth TG: Personal communication, 1974
Menghini G: One-second needle biopsy of the liver. Gastroenterology 35:190–199, 1958
Cruickshank JG, Swanepoel R: Australia antigen—Rhodesia. Cent Afr J Med 17:205–209, 1971
Ashworth TG: Alpha-feto protein in hepatoma in Rhodesia. Cent Afr J Med 20:5–7, 1974
Van de Kamer JH, Ten Bokkel Huinink H, Weyers HA: Rapid method for the determination of fat in faeces. J Biol Chem 177:347–355, 1949
Wicks ACB, Thomas GE, Clain DJ, Loon N, Siggie J, Brampston B: In preparation, 1976
Clain DJ, Freston J, Kreel L, Sherlock S: Clinical diagnosis of the Budd-Chiari syndrome. Am J Med 43:544–554, 1967
Geddes EW, Falkson G: Malignant hepatoma in the Bantu. Cancer 25:1271–1278, 1970
Vogel CL, Linsell CA: International symposium on hepatocellular carcinoma—Kampala, Uganda. J Natl Cancer Inst 48:567–571, 1972
Falkson G: Proceedings of an International Liver Conference, Cape Town. London, Pitman, 1973, p 313
Williams AO: Proceedings of an International Liver Conference, Cape Town. London, Pitman, 1973, p 309–310
Wicks ACB, Lowe RF, Jones JJ, Alcohol: A cause of diabetes in Rhodesia. S Afr Med J 48:1115–1117, 1974
Alpert ME, Hutt MSR, Davidson CS: Primary hepatoma in Uganda. Am J Med 46:794–802, 1969
Kew MC, Dos Santos HA, and Sherlock S: Diagnosis of primary cancer of the liver. Br Med J 4:408–411, 1971
MacDonald RA: Primary carcinoma of the liver. Arch Intern Med 99:266–279, 1957
Gelfand M, Castle WM, Buchanan WM: Primary carcinoma of the liver (hepatoma) in Rhodesia. S Afr Med J 46:527–532, 1972
Bagshawe AF: Proceedings of an International Liver Conference, Cape Town London, Pitman, 1973, p 299–304
Chan KT: The management of primary liver carcinoma. Ann R Coll Surg Engl 41:253–282, 1967
Clain DJ, Wartnaby K, Sherlock S: Abdominal arterial murmurs in liver disease. Lancet 2:516–519, 1966
Mabin TA, Gelfand M: Cullen's sign, a feature of liver disease. Br Med J 1:493–494, 1974
Gelfand M: Clinical aspects of cirrhosis and carcinoma of the liver in Rhodesia and Nyasaland. Acta Unio Int Contra Cancrum 17:604–615, 1961.
Bersohn I, Purves LR, Geddes EW: Liver function tests in primary cancer of the liver in the Bantu. S Afr Med J 43:1219–1225, 1969
Moseley RV: Primary malignant tumours of the liver. Surgery 61:674–686, 1967
Kay CJ: Primary hepatic cancer. Arch Intern Med 113:46–53, 1964
Ross RS, Iber FL, Harvey AM: The serum alkaline phosphatase in chronic infiltrative disease of the liver. Am J Med 21:850–856, 1956
Popper H, Schaffner F: Liver Structure and Function. New York, McGraw-Hill, 1957
Saragoga A, Barros B, Soares CS: Primary neoplasms of the liver: The possibility of biochemical diagnosis. Am J Dig Dis 9:337–344, 1964
Ellis P: Personal communication, 1975
Seggie J, Gelfand M: Serum alpha-feto protein in hepatoma in Rhodesia. Trans R Soc Trop Med Hyg 69:209–211, 1975
Smith JA, Francis TI: Immunoepidemiological andin vitro studies of possible relationships between Australia antigen and hepatocellular carcinoma. Cancer Res 32:1713–1720, 1972
Purves LR, MacNab M, Bersohn I: Serum alpha-feto protein. S Afr Med J 42:1138–1141, 1968
Vogel CL, Anthony PP, Mody N, Barker LF: Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet 2:621–624, 1970
Simmons MT, Yap EH, Yu M, Seah CS, Chew BK, Fung WP, Tang AYO, Shanmuguratnam K: Australia antigen in Singapore Chinese patients with hepatocellular carcinoma. Lancet 1:1149–1151, 1971
Welsh JD, Brown JN, Arnolo K, Chandler AM, Man HM, Thuc TK: Hepatitis-associated antigen in hepatoma in South Vietnam. Lancet 1:592, 1972
Foli AK, Sherlock S, Adinolti M: Serum alpha-feto protein in patients with liver disease. Lancet 2:1267–1269, 1969
Alpert E, Hershberg R, Schur PH, Isselbacher KJ: Alpha-feto protein in human hepatoma. Gastroenterology 61:137–143, 1971
Seggie J, Gelfand M: Hepatitis-associated antigen, cirrhosis and hepatoma in Rhodesia. S Afr Med J 48:1423–1424, 1974
Cruickshank JG, Swanepoel R, Lowe RF, Robertson T, Moore H: Australia antigen—Rhodesia. 2. Cent Afr J Med 18:113–116, 1972
Moffat HJ, Gelfand M: Viral hepatitis in Africans in Rhodesia. Cent Afr J Med 20:245–250, 1974
Smith JB, Blumberg HS: Viral hepatitis, postnecrotic cirrhosis, and hepatocellular carcinoma. Lancet 2:953, 1969
Blumberg BS, Sutnick AI, London WT: Australia antigen as a hepatitis virus. Am J Med 48:1–8, 1970
Okochi K, Murakami S: Observations on Australia antigen in Japanese. Vox Sang 15:374–385, 1968
Hadziyannis SJ, Merika GE, Afrondakis AP: Hepatitis-associated antigen in chronic liver disease. Lancet 2:100, 1970
Anand S, Malaviya AN: H.A.A. in primary liver cell carcinoma. Lancet 2:1032–1033, 1971
Teres J, Guardia J, Bruguera M, Rodes J: Hepatitis-associated antigen and hepatocellular carcinoma. Lancet 2:215, 1971
Tong MJ, Sun Shih-Chien, Schaeffer BT, Nai-Kwei Change, Kwang-Jaei L, and Peters RL: Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann Intern Med 75:687–691, 1971
Kew MC, Geddes EW, MacNab GM, Bersohn I: Hepatitis-B antigen and cirrhosis in Bantu patients with primary liver cancer. Cancer 34:539–541, 1974
Megyesi CG, Samols E, Marks V: Glucose tolerance and diabetes in chronic liver disease. Lancet 2:1051–1056, 1967
De Bruin EJP, Meyer BJ: Insulin secretion in Bantu with siderosis or hepatoma. S Afr Med J 45:892–896, 1971
Nadler WH, Wolfer JA: Hepatogenic hypoglycaemia associated with primary liver cell carcinoma. Arch Intern Med 44:700–710, 1929
Beers DN, Norton JJ: Primary carcinoma of the liver with hypoglycaemia. Am J Cancer 24:51–55, 1935
Thompson CM, Hilterty DJ: Primary carcinoma of the liver (cholangioma) with hypoglycaemic convulsions. Gastroenterology 20:158–165, 1952
Klein H, Klein SP: Spontaneous hypoglycaemia associated with massive hepatoma. Arch Intern Med 103:273–278, 1959
Vinik AI, Deppe WM: Studies on hypoglycaemia in primary carcinoma of the liver. S Afr Med J 47:518–524, 1973
Wilbur DL, Wood DA, Willet FM: Primary carcinoma of the liver. Ann Intern Med 20:453–485, 1944
Sanford CH: Primary malignant disease of the liver. Ann Intern Med 37:304–312, 1952
Strong GF, Pitts HH, McPhee JG: Primarry carcinoma of the liver-25 year study. Ann Intern Med 30:791–798, 1949
Buchanan WM: Cirrhosis and bilharzial fibrosis of the liver in Rhodesia. Cent Afr J Med 17:139–144, 1971
Scheuer PI: Liver Biopsy Interpretation, London, Bailliere, Tindal and Cassell, 1968, p 60
Buchanan WM: Bantu siderosis—a review. Cert Afr J Med 15:105–113, 1969
Van Rensburg SJ, Van Der Watt JJ, Purchase IFH, Pereira Coutinho L, Markham R: Primary liver cancer rate and aflatoxin intake in a high cancer area. S Afr Med J 48:2508a-2508d, 1974
Hutt MSR: Liver Cancer. International Agency for Research on Cancer, Scientific Publication No. 1, Lyon 21, 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomas, G.E., Wicks, A.C.B., Clain, D.J. et al. Hepatocellular carcinoma in the Rhodesian African. Digest Dis Sci 22, 573–581 (1977). https://doi.org/10.1007/BF01073074
Issue Date:
DOI: https://doi.org/10.1007/BF01073074